Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Prospective clinical study designed to evaluate damage to the heart after receiving standard of care chemotherapy and radiation therapy for locally advanced Non-Small Cell Lung Cancer (NSCLC).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Zaawansowany rak płuca (stadium III), potwierdzony badaniem
- •Będzie Pan/Pani leczony standardową chemioterapią i radioterapią
- •Guz znajduje się blisko serca lub w obszarze narażonym na dużą dawkę promieniowania
✗ Disqualifies
- •Wcześniejsza radioterapia klatki piersiowej
- •Ciężka alergia na kontrast jodowy (dotyczy niektórych badań)
- •Poważne problemy z nerkami
- •Problemy z sercem: zaburzenia przewodzenia lub bradykardia bez rozrusznika
- •Astma lub COPD z aktualnym napadem w dniu badania
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 12, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, United States
Trial contact
Jessica Anders
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/13/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.